Xue Hao

Xue Hao

Auto-generated profile, based on publicly available information

Xue Hao

Department of Experimental Therapeutics, University of Texas MD Anderson Cancer Center, Houston, TX, USA

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2019 in Zoological Research
Verified
Journal Article
Open access
PDF file
JMJames Mwangi
James Mwangi
XHXue Hao
Xue Hao
RLRen Lai
Ren Lai
Zhiye ZhangZhiye Zhang
Zhiye Zhang
The discovery of antibiotics marked a golden age in the revolution of human medicine. However, decades later, bacterial infections remain a global healthcare threat, and a return to the pre-antibiotic era seems inevitable if stringent measures are not adopted to curb the rapid emergence and spread of multidrug resistance and the indiscriminate use of antibiotics. In hospital settings, multidrug resistant (MDR) pathogens, including carbapenem-resistant Pseudomonas aeruginosa, vancomycin-resistant enterococci (VRE), methicillin-resistant Staphylococcus aureus (MRSA), and extended-spectrum β-lactamases (ESBL) bearing Acinetobacter baumannii, Escherichia coli, and Klebsiella pneumoniae are amongst the most problematic due to the paucity of treatment options, increased hospital stay, and exorbitant medical costs. Antimicrobial peptides (AMPs) provide an excellent potential strategy for combating these threats. Compared to empirical antibiotics, they show low tendency to select for resistance, rapid killing action, broad-spectrum activity, and extraordinary clinical efficacy against several MDR strains. Therefore, this review highlights multidrug resistance among nosocomial bacterial pathogens and its implications and reiterates the importance of AMPs as next-generation antibiotics for combating MDR superbugs.

5 March 2018 in Nature Immunology
Verified
Journal Article
Closed access
PDF file
LJLin Jin
Lin Jin
XGXiaomin Guo
Xiaomin Guo
CSChuanbin Shen
Chuanbin Shen
XHXue Hao
Xue Hao
PSPeng Sun
Peng Sun
Ren LaiRen Lai
Ren Lai

18 July 2022 in Nature Cell Biology
Verified
Journal Article
Closed access
PDF file
XHXue Hao
Xue Hao
YSYusuke Shiromoto
Yusuke Shiromoto
MSMasayuki Sakurai
Masayuki Sakurai
MTMartina Towers
Martina Towers
QZQiang Zhang
Qiang Zhang
RZRugang Zhang
Rugang Zhang

1 January 2021 in iScience
Verified
Journal Article
Open access
XHXue Hao
Xue Hao
BZBo Zhao
Bo Zhao
WZWei Zhou
Wei Zhou
HLHeng Liu
Heng Liu
TFTakeshi Fukumoto
Takeshi Fukumoto
RZRugang Zhang
Rugang Zhang
Therapy-induced senescence-associated secretory phenotype (SASP) correlates with overcoming resistance to immune checkpoint blockade (ICB). Intrinsic resistance to ICB is a major clinical challenge. For example, ovarian cancer is largely resistant to ICB. Here we show that adoptive transfer of SASP-boosted ex vivo therapy-induced senescent cells sensitizes ovarian tumor to ICB. Topoisomerase 1 (TOP1) inhibitors such as irinotecan enhance cisplatin-induced SASP, which depends on the TOP1 cleavage complex-regulated cGAS pathway. Significantly, intraperitoneal transfer of cisplatin-induced, SASP-boosted senescent cells with irinotecan sensitizes ovarian tumor to anti-PD-1 antibody and improves the survival of tumor-bearing mice in an immunocompetent, syngeneic model. This correlates with the infiltration of transferred senescent cells in the established orthotopic tumors and an increase in the infiltration of activated CD8+ T cells and dendritic cells in the tumor bed. Our findings indicate that adoptive transfer of SASP-boosted therapy-induced senescent cells represents a potential therapeutic strategy to sensitize tumors to ICB.

19 October 2011 in Amino Acids
Verified
Journal Article
Closed access
PDF file
XHXue Hao
Xue Hao
HYHailong Yang
Hailong Yang
LWLing Wei
Ling Wei
SYShilong Yang
Shilong Yang
WZWenjuan Zhu
Wenjuan Zhu
Ren LaiRen Lai
Ren Lai

24 January 2024 in Nature Aging
Verified
Journal Article
Closed access
PDF file
XHXue Hao
Xue Hao
BZBo Zhao
Bo Zhao
MTMartina Towers
Martina Towers
LLLiping Liao
Liping Liao
EMEdgar Luzete Monteiro
Edgar Luzete Monteiro
RZRugang Zhang
Rugang Zhang